HomeCompareRGTPQ vs MCD

RGTPQ vs MCD: Dividend Comparison 2026

RGTPQ yields 1250.00% · MCD yields 2.34%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RGTPQ wins by $135327077.51M in total portfolio value
10 years
RGTPQ
RGTPQ
● Live price
1250.00%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$135327077.59M
Annual income
$116,926,161,071,848.38
Full RGTPQ calculator →
MCD
McDonald's Corporation
● Live price
2.34%
Share price
$310.79
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$25,833.37
Full MCD calculator →

Portfolio growth — RGTPQ vs MCD

📍 RGTPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRGTPQMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RGTPQ + MCD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RGTPQ pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RGTPQ
Annual income on $10K today (after 15% tax)
$106,250.00/yr
After 10yr DRIP, annual income (after tax)
$99,387,236,911,071.11/yr
MCD
Annual income on $10K today (after 15% tax)
$198.56/yr
After 10yr DRIP, annual income (after tax)
$21,958.36/yr
At 15% tax rate, RGTPQ beats the other by $99,387,236,889,112.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RGTPQ + MCD for your $10,000?

RGTPQ: 50%MCD: 50%
100% MCD50/50100% RGTPQ
Portfolio after 10yr
$67663538.83M
Annual income
$58,463,080,548,840.88/yr
Blended yield
86.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

RGTPQ
No analyst data
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+13.2% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RGTPQ buys
0
MCD buys
0
No recent congressional trades found for RGTPQ or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRGTPQMCD
Forward yield1250.00%2.34%
Annual dividend / share$2.00$7.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3%
Portfolio after 10y$135327077.59M$77.7K
Annual income after 10y$116,926,161,071,848.38$25,833.37
Total dividends collected$133960810.96M$57.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: RGTPQ vs MCD ($10,000, DRIP)

YearRGTPQ PortfolioRGTPQ Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$135,700$125,000.00$10,812$332.41+$124.9KRGTPQ
2$1,730,479$1,585,280.37$11,819$488.02+$1.72MRGTPQ
3$20,744,959$18,893,346.29$13,111$724.37+$20.73MRGTPQ
4$233,872,934$211,675,827.14$14,832$1,091.05+$233.86MRGTPQ
5$2,480,500,804$2,230,256,765.05$17,219$1,675.85+$2480.48MRGTPQ
6$24,761,170,753$22,107,034,892.35$20,688$2,641.85+$24761.15MRGTPQ
7$232,737,122,500$206,242,669,794.36$25,990$4,309.70+$232737.10MRGTPQ
8$2,060,741,008,119$1,811,712,287,044.72$34,590$7,351.77+$2060740.97MRGTPQ
9$17,197,118,239,637$14,992,125,360,949.39$49,535$13,285.25+$17197118.19MRGTPQ
10$135,327,077,588,260$116,926,161,071,848.38$77,746$25,833.37+$135327077.51MRGTPQ

RGTPQ vs MCD: Complete Analysis 2026

RGTPQStock

RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. The company was formerly known as PolarityTE, Inc. and changed its name to RegenETP, Inc. in August 2023. RegenETP, Inc. is headquartered in Salt Lake City, Utah.

Full RGTPQ Calculator →

MCDConsumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this RGTPQ vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RGTPQ vs SCHDRGTPQ vs JEPIRGTPQ vs ORGTPQ vs KORGTPQ vs MAINRGTPQ vs YUMRGTPQ vs QSRRGTPQ vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.